Through a glass darkly: seeking clarity in preventing late kidney transplant failure
about
Computational Biology: Modeling Chronic Renal Allograft InjurySystems Biology in Kidney Transplantation: The Application of Multi-Omics to a Complex Model.The future direction and unmet needs of transplant immunosuppression.Establishment of a global virtual laboratory for transplantation: a symposium reportHigh Serum Level of β2-Microglobulin in Late Posttransplant Period Predicts Subsequent Decline in Kidney Allograft Function: A Preliminary StudyStandardized Outcomes in Nephrology-Transplantation: A Global Initiative to Develop a Core Outcome Set for Trials in Kidney Transplantation.IMPROVING LONG-TERM OUTCOMES IN KIDNEY TRANSPLANTATION: TOWARDS A NEW PARADIGM OF POST-TRANSPLANT CARE IN THE UNITED STATES.Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.Moving Biomarkers toward Clinical Implementation in Kidney Transplantation.Prohibitin protects proximal tubule epithelial cells against oxidative injury through mitochondrial pathways.Alloreactive Regulatory T Cells Allow the Generation of Mixed Chimerism and Transplant Tolerance.Research priority setting in organ transplantation: a systematic review.Polyomavirus Reactivation and Immune Responses to Kidney-Specific Self-Antigens in Transplantation.Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients.Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals.Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation: Report of the Standardized Outcomes in Nephrology-Kidney Transplantation Consensus Workshops.National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence-Based Regimen Selection.Relationships among injury, fibrosis, and time in human kidney transplants.Incidence, etiology, and significance of acute kidney injury in the early post-kidney transplant period.Correlation of Pretransplant Donor-specific Antibody Assay Using Luminex Crossmatch with Graft Outcome in Renal Transplant Patients.Relationship between eGFR Decline and Hard Outcomes after Kidney TransplantsHidden Inflammatory Molecular Signatures in Graft Kidney Biopsies: Silent Markers of Graft Fate?Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy.Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.The Impact of Anastomosis Time During Kidney Transplantation on Graft Loss: A Eurotransplant Cohort Study.Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients.Late graft failure after kidney transplantation as the consequence of late versus early events.Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus.Antibody-mediated rejection: New approaches in prevention and management.Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody.Validation of systems biology derived molecular markers of renal donor organ status associated with long term allograft function.
P2860
Q26797336-24141224-CA07-437A-AAC4-2706F5B2FAB7Q30276752-484B3552-BF28-4EB7-BF19-0ED3E900F4D9Q30277037-823FFB1A-6FB7-4948-AD94-9859AD646727Q35058541-D9D48B69-5B50-4158-8441-0C4EC4BC622DQ36304550-0F29C2CA-E23C-4DBC-B0A6-59E66485EE6CQ37097834-32EE5140-9DEB-4C6C-8886-9B2CF487B8FCQ37563822-D99757F1-17F0-47E7-9032-FD82407BE706Q38726059-1DA34D48-78B1-4773-AE32-9A52198F8715Q38773711-E336C9BC-624E-41B2-AEC9-400528C78337Q38850593-7E0C5396-D895-4ADA-B207-DFF9EA2C8F21Q38935408-81894357-54C5-45AE-A35B-51CAC9FC6893Q39102329-A390116C-0B12-4C83-B3E3-0BC8B06C2F9AQ39207543-7DC52B6A-61AE-49E3-8E5E-8F0E05745DACQ39801574-5BD5C1ED-344F-4853-9A67-E794C4F781C0Q40122293-6124DF72-A48C-4654-8FFA-6443B7023604Q40122537-D0304EC4-BCAF-429D-BDD0-FEDDB8D7CC8CQ41036267-EB70FD9D-2DF8-4093-8AE9-FCC9E6AF5DCEQ41160324-B1750669-2DC0-4DA5-985E-0AB0FD8A6800Q41189571-D151865C-25BA-423E-94E0-908316155D6AQ41514316-A42B2089-D9F6-43F4-B6C1-ED6A9DF7718FQ42722902-14B40A44-EF77-43D1-92E6-C786C14C803EQ45027499-AF5D5571-8BDF-4A41-9D07-1561F31200F9Q47157742-4DDD3C9F-974A-47C5-BD63-988C099CFA7DQ48160896-AE8AB56B-D146-477E-A30D-B64BE1F75CD6Q48371293-385DB5F2-A5AD-4259-A581-B9693BB518C5Q48955797-96C67BEA-7953-4D6E-A23F-5C231DFF7EE1Q50005462-05C5E2E7-B551-4561-93B6-3D4D15555D57Q50997883-3E946DD2-445B-46AB-9CBF-0D4FCE6BEF00Q52401610-012A05B0-E17C-4977-A029-E730E5F64111Q53459320-7725384F-69D2-4F19-AF8C-DD35DC4D419CQ55080066-8CD5CF8C-A02D-44D6-86C6-7DB83F79A7F3
P2860
Through a glass darkly: seeking clarity in preventing late kidney transplant failure
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Through a glass darkly: seeking clarity in preventing late kidney transplant failure
@en
type
label
Through a glass darkly: seeking clarity in preventing late kidney transplant failure
@en
prefLabel
Through a glass darkly: seeking clarity in preventing late kidney transplant failure
@en
P2093
P2860
P356
P1476
Through a glass darkly: seeking clarity in preventing late kidney transplant failure
@en
P2093
Arthur Matas
Fernando G Cosio
Mark D Stegall
Robert S Gaston
P2860
P356
10.1681/ASN.2014040378
P577
2014-08-05T00:00:00Z